Complications of Computed Tomography-Guided High-Dose-Rate Brachytherapy (CT-HDRBT) and Risk Factors: Results from More than 10 Years of Experience.
Georg BöningLaura BüttnerMartin JonczykWillie Magnus LüdemannTimm DeneckeDirk SchnapauffGero WienersPeter WustBernhard GebauerPublished in: Cardiovascular and interventional radiology (2019)
CT-HDRBT is a safe minimally invasive therapeutic option. Summarized diameter of treated tumor lesions, target lesion site, combined treatment, and presence of BDA are risk factors for complications.